Question 1

Has Richard Lemons received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,914,217 in general payments to Richard Lemons across 1,026 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Richard Lemons did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Richard Lemons come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
CSL Behring	806	$1,531,023
Novo Nordisk	124	$187,490
Novo Nordisk AS	77	$128,123
Pfizer	10	$45,097
Takeda Pharmaceuticals U.S.A., Inc.	2	$16,065
Novartis	5	$5,729
Sanofi	1	$375
Melinta Therapeutics, LLC	1	$315

Richard Lemons

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other pediatric hematology-oncology in Salt Lake City